mRNA |
TG-101348 |
GDSC1000 |
pan-cancer |
AAC |
-0.082 |
0.005 |
mRNA |
Rapamycin |
GDSC1000 |
pan-cancer |
AAC |
0.15 |
0.005 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.094 |
0.005 |
mRNA |
Sorafenib |
GDSC1000 |
pan-cancer |
AAC |
-0.16 |
0.005 |
mRNA |
Nilotinib |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.005 |
mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
0.087 |
0.005 |
mRNA |
prima-1 |
CTRPv2 |
pan-cancer |
AAC |
0.09 |
0.006 |
mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.006 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.093 |
0.006 |
mRNA |
masitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.091 |
0.006 |